An observational study of the universal use of octenidine to decrease nosocomial bloodstream infections and MDR organisms

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 9, 2016, Pages 2569-2576

  Gastmeier, Petra ^a   Kämpf, Klaus Peter ^a   Behnke, Michael ^a   Geffers, Christine ^a   Schwab, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTENIDINE; PYRIDINE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

CROSS INFECTION; DISINFECTION; HETEROZYGOTE; HUMAN; INTENSIVE CARE UNIT; PROCEDURES; PROSPECTIVE STUDY; SEPSIS; STAPHYLOCOCCAL INFECTIONS; UNIVERSITY HOSPITAL;

ANTI-INFECTIVE AGENTS, LOCAL; CARRIER STATE; CROSS INFECTION; DISINFECTION; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; PROSPECTIVE STUDIES; PYRIDINES; SEPSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 84994587717     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw170     Document Type: Article

References (35)

1. Lambert M, Suetens C, Savey A et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11: 30-8.
2. Prowle J, Echeverri J, Ligabo E et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care 2011; 15: R100.
3. Ziegler M, Pellegrini D, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infection 2015; 43: 29-36.
4. de Kraker M, Davey P, Grundmann H, on behalf of the BURDEN study group. Burden of resistance: Mortality and hospital stay in Europe attributable to antibiotic-resistant Staphylococcus aureus and Escherichia coli bacteremias. PLos One 2011; 8: e1001104.
5. Huang S, Septimus E, Kleinman K et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 2255-65.
6. Derde L, Cooper B, Goossens H et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014; 14: 31-9.
7. Climo M, Yokoe D, Warren D et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368: 533-42.
8. Huang S, Septimus E, Avery T et al. Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial. Infect Control Hosp Epidemiol 2014; 35 Suppl 3: S23-31.
9. Lin M, Lolans K, Blom D et al. The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among longterm acute care hospital patients. Infect Control Hosp Epidemiol 2014; 35: 440-2.
10. Chung Y, Kim J, Lee S et al. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity. Am J Infect Control 2015; 43: 1171-7.
11. Lee A, Macedo-Vinas M, François P et al. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J Hosp Infect 2011; 77: 360-2.
12. Lee A, Gizard Y, Empel J et al. Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2014; 52: 3749-54.
13. Batra R, Cooper B, Whiteley C et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010; 50: 210-7.
14. Horner C, Mawer D, Wilcox M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J Antimicrob Chemother 2012; 67: 2547-59.
15. Suwantarat N, Carroll K, Tekle T et al. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2014; 35: 1183-6.
16. Hetem D, Vogely H, Severs T et al. Acquisition of high-level mupirocin resistance in CoNS following nasal decolonization with mupirocin. J Antimicrob Chemother 2014; 70: 1182-4.
17. Poovelikunnel T, Gethin G, Humphreys H. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother 2015; 70: 2681-92.
18. Deeny S, Worby C, Tosas Auguet O et al. Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA. J Antimicrob Chemother 2015; 70: 3366-78.
19. Sedlock D, Bailey D. Microbicidal activity of octenidine hydrochloride, a new alkanediylbis[pyridine] germicidal agent. Antimicrob Agents Chemother 1985; 28: 786-90.
20. Koburger T, Hübner N, Braun M et al. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65: 1712-9.
21. Rohr U, Mueller C, Wilhelm M et al. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 2003; 54: 305-9.
22. Krishna B, Gibb A. Use of octenidine dihydrochloride in meticillinresistant Staphylococcus aureus decolonisation regimens: a literature review. J Hosp Infect 2010; 74: 199-203.
23. Spencer C, Orr D, Hallam S et al. Daily bathing with octenidine on an intensive care unit is associated with a lower carriage rate of meticillinresistant Staphylococcus aureus. J Hosp Infect 2013; 83: 156-9.
24. Harris P, Le B, Tambyah P et al. Antiseptic body washes for reducing the transmission of methicillin-resistant Staphylococcus aureus: a cluster crossover study. Open Forum Infect Dis 2015; 2: ofv051.
25. Dettenkofer M, Wilson C, Gratwohl A et al. Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a doubleblind, randomized, controlled trial. Clin Microbiol Infect 2010; 16: 600-6.
26. Al-Doori Z, Goroncy-Bermes P, Gemmell C et al. Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance. J Antimicrob Chemother 2007; 59: 1280-1.
27. Wagner A, Soumerai S, Zhang F et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27: 299-309.
28. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 842-8.
29. Zeger S, Liang K, Albert P. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44: 1049-60.
30. Morgan D, Diekema D, Sepkowitz K et al. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009; 37: 85-93.
31. Meyer E, Gastmeier P, Deja M et al. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol 2013; 303: 388-95.
32. Gastmeier P, Schröder C, Behnke M et al. Dramatic increase in vancomycin-resistant enterococci in Germany. J Antimicrob Chemother 2014; 69: 1660-4.
33. Leistner R, Schröder C, Breier A-C et al. Regional increases in nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS). Clin Microbiol Infect 2015; 21: 255.e1-5.
34. O'Horo J, Silva G, Munoz-Price S et al. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012; 33: 257-67.
35. Noto M, Domenico H, Byrne D et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 2015; 313: 369-78.